Cargando…

Deciphering the Action of Neuraminidase in Glioblastoma Models

Glioblastoma (GBM) contains cancer stem cells (CSC) that are resistant to treatment. GBM CSC expresses glycolipids recognized by the A2B5 antibody. A2B5, induced by the enzyme ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyl transferase 3 (ST8Sia3), plays a crucial role in the proliferation, migratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baeza-Kallee, Nathalie, Bergès, Raphaël, Hein, Victoria, Cabaret, Stéphanie, Garcia, Jeremy, Gros, Abigaëlle, Tabouret, Emeline, Tchoghandjian, Aurélie, Colin, Carole, Figarella-Branger, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380381/ https://www.ncbi.nlm.nih.gov/pubmed/37511403 http://dx.doi.org/10.3390/ijms241411645

Ejemplares similares

Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells
por: Baeza-Kallee, Nathalie, et al.
Publicado: (2019)

Molecular heterogeneity of glioblastomas: does location matter?
por: Denicolaï, Emilie, et al.
Publicado: (2015)

A2B5 Expression in Central Nervous System and Gliomas
por: Figarella-Branger, Dominique, et al.
Publicado: (2022)

Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma
por: Berges, Raphael, et al.
Publicado: (2018)

End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo
por: Berges, Raphael, et al.
Publicado: (2014)

Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo
por: Denicolaï, Emilie, et al.
Publicado: (2014)

Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152
por: Tchoghandjian, A, et al.
Publicado: (2016)

Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma
por: Mercurio, Sandy, et al.
Publicado: (2013)

EB1-dependent long survival of glioblastoma-grafted mice with the oral tubulin-binder BAL101553 is associated with inhibition of tumor angiogenesis
por: Bergès, Raphaël, et al.
Publicado: (2020)

Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms
por: Ariey-Bonnet, Jérémy, et al.
Publicado: (2023)

Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway
por: Tabouret, Emeline, et al.
Publicado: (2015)

Phenotypic dynamics of microglial and monocyte-derived cells in glioblastoma-bearing mice
por: Ricard, Clément, et al.
Publicado: (2016)

Differential scanning calorimetry of plasma in glioblastoma: toward a new prognostic / monitoring tool
por: Tsvetkov, Philipp O., et al.
Publicado: (2018)

Tau Regulates Glioblastoma Progression, 3D Cell Organization, Growth and Migration via the PI3K-AKT Axis
por: Pagano, Alessandra, et al.
Publicado: (2021)

Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells
por: Lamballe, Fabienne, et al.
Publicado: (2016)

Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
por: Appay, Romain, et al.
Publicado: (2018)

Practical Review on Preclinical Human 3D Glioblastoma Models: Advances and Challenges for Clinical Translation
por: Soubéran, Aurélie, et al.
Publicado: (2020)

Negative Survival Impact of High Radiation Doses to Neural Stem Cells Niches in an IDH-Wild-Type Glioblastoma Population
por: Muracciole, Xavier, et al.
Publicado: (2018)

Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study
por: Jiguet-Jiglaire, Carine, et al.
Publicado: (2022)

Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank?
por: Clavreul, Anne, et al.
Publicado: (2022)

Diffuse leptomeningeal glioneuronal tumor: a double misnomer? A report of two cases
por: Appay, Romain, et al.
Publicado: (2020)

The French glioblastoma biobank (FGB): a national clinicobiological database
por: Clavreul, Anne, et al.
Publicado: (2019)

Correction to: The French glioblastoma biobank (FGB): a national clinicobiological database
por: Clavreul, Anne, et al.
Publicado: (2020)

Effects of VEGF blockade on the dynamics of the inflammatory landscape in glioblastoma-bearing mice
por: Soubéran, Aurélie, et al.
Publicado: (2019)

Polysialic Acid Neural Cell Adhesion Molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines
por: Amoureux, Marie-Claude, et al.
Publicado: (2010)

Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
por: Quillien, Véronique, et al.
Publicado: (2014)

Brief CommunicationCirculating tumor DNA is present in the most aggressive meningiomas
por: Graillon, Thomas, et al.
Publicado: (2020)

An AI-Powered Blood Test to Detect Cancer Using NanoDSF
por: Tsvetkov, Philipp O., et al.
Publicado: (2021)

An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients
por: Ducray, François, et al.
Publicado: (2010)

Mitochondrial DNA copy number as a prognostic marker is age-dependent in adult glioblastoma
por: Sourty, Baptiste, et al.
Publicado: (2022)

Deciphering the complex role of thrombospondin-1 in glioblastoma development
por: Daubon, Thomas, et al.
Publicado: (2019)

Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
por: Picart, Thiébaud, et al.
Publicado: (2021)

Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma
por: Joshkon, Ahmad, et al.
Publicado: (2022)

Otx2 promotes granule cell precursor proliferation and Shh-dependent medulloblastoma maintenance in vivo
por: El Nagar, Salsabiel, et al.
Publicado: (2018)

An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas
por: Laffaire, Julien, et al.
Publicado: (2014)

Multiplexed Droplet Digital PCR Assays for the Simultaneous Screening of Major Genetic Alterations in Tumors of the Central Nervous System
por: Appay, Romain, et al.
Publicado: (2020)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Deciphering the Role of Autophagy in Treatment of Resistance Mechanisms in Glioblastoma
por: Khan, Imran, et al.
Publicado: (2021)

Inhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design
por: Zhu, Qinchang, et al.
Publicado: (2015)

DGKI Methylation Status Modulates the Prognostic Value of MGMT in Glioblastoma Patients Treated with Combined Radio-Chemotherapy with Temozolomide
por: Etcheverry, Amandine, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l4qjoc6a9973map3d6024bs8de